These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2945684)

  • 1. Serum IgA levels and ANA behaviour in rheumatoid patients with and without toxicity to remission-inducing drugs.
    Ferraccioli GF; Nervetti A; Mercadanti M; Cavalieri F
    Clin Exp Rheumatol; 1986; 4(3):217-20. PubMed ID: 2945684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity due to remission inducing drugs in rheumatoid arthritis. Association with HLA-B35 and Cw4 antigens.
    Ferraccioli G; Peri F; Nervetti A; Ambanelli U; Savi M
    J Rheumatol; 1986 Feb; 13(1):65-8. PubMed ID: 3084782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between DR3 and thrombocytopenia due to gold or tiopronin. Case reports and review of the literature.
    Ferraccioli GF; Cavalieri F; Mercadanti M; Salaffi F; Ambanelli U; Savi M
    Clin Exp Rheumatol; 1985; 3(4):341-3. PubMed ID: 3910323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome with gold thiosulphate and tiopronin in 200 rheumatoid patients.
    Ferraccioli GF; Salaffi F; Nervetti A; Manganelli P
    Clin Exp Rheumatol; 1989; 7(6):577-81. PubMed ID: 2515016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rare side effects of gold].
    Stollenwerk R; Annefeld M; Schilling F; Dreher R
    Z Rheumatol; 1986; 45(3):107-10. PubMed ID: 2944309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucocutaneous toxicity of gold salts by parenteral administration--rechallenge with auranofin.
    Tumiati B; Veneziani M; Bellelli A; Portioli I
    J Rheumatol; 1987 Feb; 14(1):177. PubMed ID: 2952794
    [No Abstract]   [Full Text] [Related]  

  • 7. Tiopronin-nephropathy: clinical, pathological, immunological and immunogenetic characteristics.
    Ferraccioli GF; Peri F; Nervetti A; Mercadanti M; Cavalieri F; Dall'Aglio PP; Savi M; Ferrari C
    Clin Exp Rheumatol; 1986; 4(1):9-15. PubMed ID: 3516496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Myasthenia caused by tiopronin during treatment of rheumatoid polyarthritis].
    Menkes CJ; Job-Deslandre C; Bauer-Vinassac D; Rouillon A; Rousseau R
    Presse Med; 1988 Jun; 17(22):1156-7. PubMed ID: 2969543
    [No Abstract]   [Full Text] [Related]  

  • 9. [A study of drug eruptions due to tiopronin].
    Ichikawa S; Shida Y; Nagano I; Shimizu M
    Nihon Hifuka Gakkai Zasshi; 1988 Jan; 98(1):1-8. PubMed ID: 2969988
    [No Abstract]   [Full Text] [Related]  

  • 10. Lupus like syndrome induced by 2-mercaptopropionylglycine.
    Katayama I; Nishioka K
    J Dermatol; 1986 Apr; 13(2):151-3. PubMed ID: 3531274
    [No Abstract]   [Full Text] [Related]  

  • 11. Tiopronin (N-[2-mercaptopropionyl] glycin) in rheumatoid arthritis.
    Amor B; Mery C; de Gery A
    Arthritis Rheum; 1982 Jun; 25(6):698-703. PubMed ID: 7046758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiopronine-induced pemphigus vulgaris in rheumatoid arthritis.
    Trotta F; Scaramelli M; Cervi G; Virgili AR
    Scand J Rheumatol; 1984; 13(1):93-5. PubMed ID: 6719065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lichen ruber pemphigoid in gold treatment of rheumatoid arthritis].
    Wozel G; Rietzschel I; Heidenbluth I
    Dermatol Monatsschr; 1983 Feb; 169(2):125-9. PubMed ID: 6404668
    [No Abstract]   [Full Text] [Related]  

  • 14. [Extracapillary proliferative glomerulonephritis and pulmonary purpura in a patient with rheumatoid arthritis treated with gold salts].
    Bontempini L; Colombari R; Lupo A; Malena M; Doglioni C; Ghimenton C
    Pathologica; 1986; 78(1057):647-55. PubMed ID: 3114704
    [No Abstract]   [Full Text] [Related]  

  • 15. Absence of gold sodium thiosulfate contact hypersensitivity in rheumatoid arthritis.
    Fleming C; Porter D; MacKie R
    Contact Dermatitis; 1998 Jan; 38(1):55-6. PubMed ID: 9504259
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oral lichenoid reaction secondary to gold salt therapy].
    Vallejo Irastorza G; López Cedrún JL; Marínez-Conde R; Aguirre Urízar JM
    Av Odontoestomatol; 1990 Feb; 6(2):131-3. PubMed ID: 2118353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary biliary cirrhosis. A patient with adverse reactions to tiopronin and autoimmune hemolytic anemia with reticulocytopenia.
    Shichiri M; Koyama W; Tozuka S; Sakamoto S; Kanayama M
    Arch Intern Med; 1984 Jan; 144(1):89-91. PubMed ID: 6229229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [2 cases of kidney damage during the treatment with gold preparations].
    Wanic-Kossowska M; Turczak-Bierła I; Grzegorzewska A
    Przegl Lek; 1990; 47(11):788-90. PubMed ID: 2129137
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypersensitivity to gold in gold sodium thiomalate-induced dermatosis.
    Räsänen L; Kaipiainen-Seppänen O; Myllykangas-Luosujärvi R; Käsnänen T; Pollari P; Saloranta P; Horsmanheimo M
    Br J Dermatol; 1999 Oct; 141(4):683-8. PubMed ID: 10583116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypogammaglobulinaemia associated with gold therapy.
    Hunter T
    Ann Rheum Dis; 1985 Mar; 44(3):212. PubMed ID: 3919662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.